CodeMap® 
150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-January
2024-October

ASC Fee Schedule

2025-January
2024-October

APC Codes

2025-January
2024-October

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-January
2024-October


CMS Transmittals



.


CodeMap® Compliance Briefing: March 4, 2016


Editor's Welcome:

Most new clinical applications of mass spectrometry are evolving without the benefit of appropriate reimbursement policy by Medicare and other commercial payers. At the same time, the overutilization of urine drug testing in pain management has resulted in draconian cuts to reimbursement for testing performed using traditional chromatography/mass spectrometry methods. These developments have placed providers that perform mass spectrometry in a difficult and uncertain place. The following briefing will discuss the coding and reimbursement issues that have recently developed concerning mass spectrometry

Sincerely,

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.